Vivaldi Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $625K | Buy |
5,197
+172
| +3% | +$19.9K | 0.09% | 140 |
|
|
2025
Q4 | $529K | Buy |
5,025
+24
| +0.5% | +$2.25K | 0.07% | 156 |
|
|
2025
Q3 | $420K | Sell |
5,001
-3,818
| -43% | -$314K | 0.06% | 176 |
|
|
2025
Q2 | $698K | Sell |
8,819
-191
| -2% | -$15.2K | 0.1% | 128 |
|
|
2025
Q1 | $809K | Buy |
9,010
+69
| +0.8% | +$6.44K | 0.13% | 116 |
|
|
2024
Q4 | $876K | Buy |
8,941
+702
| +9% | +$72.4K | 0.13% | 115 |
|
|
2024
Q3 | $936K | Buy |
8,239
+55
| +0.7% | +$6.53K | 0.27% | 80 |
|
|
2024
Q2 | $1.01M | Buy |
8,184
+385
| +5% | +$49.6K | 0.29% | 90 |
|
|
2024
Q1 | $1.01M | Sell |
7,799
-285
| -4% | -$35.1K | 0.3% | 86 |
|
|
2023
Q4 | $1.01M | Buy |
8,084
+630
| +8% | +$65.4K | 0.3% | 85 |
|
|
2023
Q3 | $767K | Buy |
7,454
+170
| +2% | +$18.3K | 0.25% | 87 |
|
|
2023
Q2 | $841K | Buy |
7,284
+355
| +5% | +$40.3K | 0.26% | 86 |
|
|
2023
Q1 | $737K | Sell |
6,929
-156
| -2% | -$16.8K | 0.22% | 93 |
|
|
2022
Q4 | $782K | Buy |
7,085
+208
| +3% | +$21.3K | 0.19% | 108 |
|
|
2022
Q3 | $602K | Buy |
6,877
+48
| +0.7% | +$4.29K | 0.16% | 108 |
|
|
2022
Q2 | $623K | Buy |
6,829
+237
| +4% | +$21K | 0.16% | 107 |
|
|
2022
Q1 | $596K | Buy |
6,592
+93
| +1% | +$7.33K | 0.16% | 114 |
|
|
2021
Q4 | $498K | Buy |
6,499
+24
| +0.4% | +$1.91K | 0.12% | 123 |
|
|
2021
Q3 | $486K | Hold |
6,475
| – | – | 0.11% | 133 |
|
|
2021
Q2 | $497K | Sell |
6,475
-1,074
| -14% | -$79.9K | 0.1% | 138 |
|
|
2021
Q1 | $564K | Sell |
7,549
-259
| -3% | -$19.1K | 0.11% | 135 |
|
|
2020
Q4 | $609K | Buy |
7,808
+524
| +7% | +$40.1K | 0.13% | 123 |
|
|
2020
Q3 | $564K | Buy |
7,284
+3,501
| +93% | +$274K | 0.13% | 130 |
|
|
2020
Q2 | $298K | Sell |
3,783
-917
| -20% | -$69K | 0.06% | 196 |
|
|
2020
Q1 | $344K | Buy |
4,700
+214
| +5% | +$16.8K | 0.08% | 143 |
|
|
2019
Q4 | $388K | Sell |
4,486
-1,490
| -25% | -$122K | 0.09% | 149 |
|
|
2019
Q3 | $480K | Buy |
5,976
+2,182
| +58% | +$175K | 0.11% | 127 |
|
|
2019
Q2 | $303K | Buy |
3,794
+412
| +12% | +$31.5K | 0.08% | 185 |
|
|
2019
Q1 | $268K | Sell |
3,382
-407
| -11% | -$30.4K | 0.07% | 191 |
|
|
2018
Q4 | $276K | Sell |
3,789
-250
| -6% | -$17.6K | 0.12% | 145 |
|
|
2018
Q3 | $273K | Buy |
4,039
+22
| +0.5% | +$1.4K | 0.15% | 107 |
|
|
2018
Q2 | $233K | Buy |
4,017
+67
| +2% | +$3.78K | 0.19% | 112 |
|
|
2018
Q1 | $205K | Sell |
3,950
-3
| -0.1% | -$162 | 0.15% | 120 |
|
|
2017
Q4 | $212K | Sell |
3,953
-179
| -4% | -$9.92K | 0.18% | 112 |
|
|
2017
Q3 | $252K | Buy |
4,132
+50
| +1% | +$3.03K | 1.08% | 51 |
|
|
2017
Q2 | $250 | Buy |
+4,082
| New | +$248K | ﹤0.01% | 76 |
|
Other funds holding MRK
VCM
VPM
Vivaldi Capital Management's MRK Position: Q1 2026 in Review
Vivaldi Capital Management increased its Merck (MRK) stake by 3.4% in Q1 2026, buying an estimated $19.9K and bringing the position to 5,197 shares worth $625K. The position accounts for 0.09% of the portfolio, ranked #140.
Vivaldi Capital Management first reported a position in MRK in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.01M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Vivaldi Capital Management held 5,197 shares of Merck worth $625K as of Q1 2026.
- Vivaldi Capital Management bought 172 Merck shares in Q1 2026, an estimated $19.9K.
- Merck made up 0.09% of Vivaldi Capital Management's portfolio in Q1 2026, its #140 holding.
- Vivaldi Capital Management first reported a position in Merck in Q2 2017 and has held it in 36 quarters since.
- Vivaldi Capital Management's Merck position peaked at $1.01M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Vivaldi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.